Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9596 posts found.

Right time, right place, right patient

January 17, 2006 Research and Development

With patient recruitment such a key cog in the overall clinical trial machine, pharma and biotech businesses are increasing their …
Feature

Gene discovery offers new diabetes drug target hope

January 16, 2006 Research and Development

A gene thought to be present in around 20% of type II diabetes patients has been identified, opening up the …
News

Wanted: Innovative drugs

January 12, 2006 Research and Development prix galien

When the UK government last month announced a series of measures to boost research and development in the NHS, its …
Feature

AstraZeneca buys UK cancer research firm

January 4, 2006 Research and Development

AstraZeneca has bought a small UK biotech company KuDOS which specialises in cutting edge cancer research.AstraZeneca made its name in …
News

AstraZeneca doubles trial size for stroke drug

December 13, 2005 Research and Development AstraZeneca, stroke

 Late stage clinical trials of AstraZeneca’s new stroke treatment have resumed after the company decided to double the number of …
News

350 million needed for stem cell research

December 8, 2005 Research and Development

At least £350 million extra funding is needed for UK stem cell research if it is to maintain its international …
News

McKillop calls for changes to EU pharmaceutical market

December 8, 2005 Research and Development

AstraZeneca's chief executive Sir Tom McKillop says action is needed on pricing and the clinical trials environment in order to …
News

UK biotech signs $230 million deal with Genentech

December 7, 2005 Research and Development

UK biotech PIramed has signed a collaborative R&D deal with Genentech on a new class of cancer drugs, which could …
News

Pharma unprepared for shift to secondary care

November 28, 2005 Research and Development

Nine out of ten European pharmaceutical companies believe they need to make significant changes to their businesses as a result …
News

New antibody could be COPD breakthrough, say companies

November 21, 2005 Research and Development Argenta, COPD, Domantis

 Two UK biotech companies say their innovative antibody drug could be a breakthrough in treating the chronic respiratory disease COPD.Chronic …
News

Oxford and GSK to collaborate on cancer research in India

November 18, 2005 Research and Development

The University of Oxford and GlaxoSmithKline are to work together with researchers in India to set up the country's first …
News

Study results not IDEAL for Lipitor

November 16, 2005 Research and Development, Sales and Marketing

A new study of Lipitor failed to show it was better than Merck's Zocor at preventing major coronary events.Results showing …
News

Enhancing the drug development process

November 9, 2005 Research and Development

MEDICAL SOLUTIONS SPONSORED FEATURERecently, we have seen a massive increase in our knowledge and understanding of the biochemical mechanisms that, …
Feature

US acquisitions a coup for Cambridge Antibody

November 8, 2005 Research and Development

Cambridge Antibody Technology has bought two promising oncology candidates from US biotech company Genencor, and has established its first research …
News

R&D Scoreboard poor gauge of pharma investment in the UK

November 8, 2005 Research and Development AstraZeneca, GSK, Pfizer, R&D, R&D scoreboard

 The R&D Scoreboard is fundamentally flawed as a measure of R&D investment in the UK and pharmaceutical companies are continuing …
News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026